Prion formation, but not clearance, is supported by protein misfolding cyclic amplification

被引:7
|
作者
Shikiya, Ronald A. [1 ]
Eckland, Thomas E. [1 ]
Young, Alan J. [2 ]
Bartz, Jason C. [1 ]
机构
[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68102 USA
[2] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA
基金
美国国家卫生研究院;
关键词
prion clearance; prion disease; protein misfolding cyclic amplification; TRANSMISSIBLE MINK ENCEPHALOPATHY; IN-VITRO GENERATION; SCRAPIE AGENT; MOUSE SCRAPIE; PRPSC; REPLICATION; CONFORMATIONS; RESISTANT; INFECTION; STRAINS;
D O I
10.4161/19336896.2014.983759
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases are fatal transmissible neurodegenerative disorders that affect animals including humans. The kinetics of prion infectivity and PrPSc accumulation can differ between prion strains and within a single strain in different tissues. The net accumulation of PrPSc in animals is controlled by the relationship between the rate of PrPSc formation and clearance. Protein misfolding cyclic amplification (PMCA) is a powerful technique that faithfully recapitulates PrPSc formation and prion infectivity in a cell-free system. PMCA has been used as a surrogate for animal bioassay and can model species barriers, host range, strain co-factors and strain interference. In this study we investigated if degradation of PrPSc and/or prion infectivity occurs during PMCA. To accomplish this we performed PMCA under conditions that do not support PrPSc formation and did not observe either a reduction in PrPSc abundance or an extension of prion incubation period, compared to untreated control samples. These results indicate that prion clearance does not occur during PMCA. These data have significant implications for the interpretation of PMCA based experiments such as prion amplification rate, adaptation to new species and strain interference where production and clearance of prions can affect the outcome.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [21] Protein misfolding cyclic amplification of infectious prions
    Morales, Rodrigo
    Duran-Aniotz, Claudia
    Diaz-Espinoza, Rodrigo
    Camacho, Manuel V.
    Soto, Claudio
    NATURE PROTOCOLS, 2012, 7 (07) : 1397 - 1409
  • [22] Protein misfolding cyclic amplification of infectious prions
    Rodrigo Morales
    Claudia Duran-Aniotz
    Rodrigo Diaz-Espinoza
    Manuel V Camacho
    Claudio Soto
    Nature Protocols, 2012, 7 : 1397 - 1409
  • [23] Protein Misfolding Cyclic Amplification of Infectious Prions
    Moda, Fabio
    PRION PROTEIN, 2017, 150 : 361 - 374
  • [24] Cavitation during the protein misfolding cyclic amplification (PMCA) method - The trigger for de novo prion generation?
    Haigh, Cathryn L.
    Drew, Simon C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 461 (03) : 494 - 500
  • [25] Prion Protein Misfolding
    Kupfer, L.
    Hinrichs, W.
    Groschup, M. H.
    CURRENT MOLECULAR MEDICINE, 2009, 9 (07) : 826 - 835
  • [26] Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification
    Imamura, Morikazu
    Tabeta, Naoko
    Kato, Nobuko
    Matsuura, Yuichi
    Iwamaru, Yoshifumi
    Yokoyama, Takashi
    Murayama, Yuichi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (51) : 26478 - 26486
  • [27] Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification
    Moudjou, Mohammed
    Chapuis, Jerome
    Mekrouti, Meriem
    Reine, Fabienne
    Herzog, Laetitia
    Sibille, Pierre
    Laude, Hubert
    Vilette, Didier
    Andreoletti, Olivier
    Rezaei, Human
    Dron, Michel
    Beringue, Vincent
    SCIENTIFIC REPORTS, 2016, 6
  • [28] Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification
    Mohammed Moudjou
    Jérôme Chapuis
    Mériem Mekrouti
    Fabienne Reine
    Laetitia Herzog
    Pierre Sibille
    Hubert Laude
    Didier Vilette
    Olivier Andréoletti
    Human Rezaei
    Michel Dron
    Vincent Béringue
    Scientific Reports, 6
  • [29] Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays
    Boerner, Susann
    Wagenfuehr, Katja
    Daus, Martin L.
    Thomzig, Achim
    Beekes, Michael
    LABORATORY ANIMALS, 2013, 47 (02) : 106 - 115
  • [30] Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification
    Jung, Byung Chul
    Lim, Yoon-Ju
    Bae, Eun-Jin
    Lee, Jun Sung
    Choi, Min Sun
    Lee, Michael K.
    Lee, He-Jin
    Kim, Yoon Suk
    Lee, Seung-Jae
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 : e314 - e314